NDATOPICALCREAM
Approved
Jun 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
HALOG (halcinonide) by Bristol Myers Squibb is corticosteroid hormone receptor agonists [moa]. First approved in 1977.
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HALOG (halcinonide) is a topical corticosteroid cream that acts as a corticosteroid hormone receptor agonist. It is used to treat inflammatory and pruritic dermatological conditions. The drug works by binding to corticosteroid receptors to reduce inflammation and itching in affected skin areas.
LOE Approaching
Product faces approaching loss of exclusivity with moderate competitive pressure (30), indicating a contracting brand team focused on generic transition planning.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Study of the Role of Top-down Processes in Neuronal Reorganization and Recovery From Sensory Loss: an Exploratory Behavioral and Electroencephalographic Study in Cochlear-supported Deaf Patients
Started Mar 2026
90 enrolled
Deafness, Bilateral
A Study to Evaluate Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) in Participants With Major Depressive Disorder (MDD)
Started Nov 2025
80 enrolled
Depressive Disorder, Major
Development of Electroencephalography (EEG) and Magnetoencephalography (MEG) Source Reconstruction With Fast Multipole Method
Started Jan 2025
30 enrolled
Healthy
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
Started Jan 2024
99 enrolled
Cannabis UseAlcohol Use, Unspecified
Safety and Performance Study of the Electroencephalographic Recording Device and Sound Emissions
Started Oct 2023
0Sleep Disorder
Worked on HALOG at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.